Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Mitchell
News Release
FDA Authorizes Second Coronavirus (SARS-CoV2) Vaccine for Use
On December 18, 2020, one week after authorizing the first SARS-CoV2 vaccine (Pfizer) for emergency use, the U.S.
Workers' Comp
Blog
Network 2.0 - Constructive partnerships between providers and payers
In our last blog post we discussed how networks help to manage the relationship with the provider and allow patients to sidest
Mitchell
News Release
Mitchell Predicts 2021 Trends in Its Fourth Quarter 2020 Industry Trends Report
SAN DIEGO, CA—Mitchell International, Inc., a leading provider of technology, connectivity and information solutions to the proper
Mitchell
News Release
FDA Authorizes Pfizer/BioNTech COVID-19 Vaccine for Emergency Use
On December 11, 2020, the
Workers' Comp
News Release
AvKARE Issues Voluntary Nationwide Recall of Certain Sildenafil and Trazodone Tablets
AvKARE, Inc., a subsidiary of Amneal Pharmaceuticals located in Pulaski, Tennessee,
Auto Physical Damage
News Release